{"product_id":"dsm-firmenich-pestle-analysis","title":"DSM-Firmenich PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMake Smarter Strategic Decisions with a Complete PESTEL View\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock strategic clarity with our DSM‑Firmenich PESTLE Analysis—concise, evidence‑based insights into political, economic, social, technological, legal and environmental forces shaping the company. Ideal for investors, consultants and strategists, it highlights risks, regulatory pressures and growth opportunities. Save research time and make sharper decisions. Purchase the full, downloadable report for the complete breakdown.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTrade policies and tariffs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eTrade rules on food, chemicals and pharma ingredients directly affect DSM-Firmenich’s market access and input costs: WTO data shows average MFN tariffs ~13.5% for agricultural goods and ~3.5% for chemical products, implying tariffs on vitamins, amino acids or aroma chemicals can shave several percentage points off margins or force sourcing shifts. Regional trade agreements (EU, CPTPP, USMCA) lower duties and enable supply‑chain optimization but require compliance adjustments, while geopolitics has driven ~1,800 trade‑restrictive measures in 2022–24, increasing tariff volatility and hedging needs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeopolitical supply-chain risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eConflict and sanctions can disrupt key inputs like fermentation feedstocks, botanicals or solvents; over 40% of active pharmaceutical ingredients and many botanicals are sourced from China\/India, raising exposure for DSM‑Firmenich supply chains. Diversified manufacturing footprints across Europe, the Americas and Asia reduce single‑country risk. Contingency inventory, multi‑sourcing and nearshoring are essential to maintain service levels. Political instability in emerging suppliers requires enhanced real‑time risk monitoring.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAgricultural and nutrition policy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eGovernment farm subsidies and crop mandates affect raw-material prices and availability, requiring supply-chain hedging since DSM-Firmenich's 2023 merger expanded upstream exposure. Public nutrition programs (around 2 billion people with micronutrient deficiencies) boost fortification demand. WHO's 30% salt-reduction target by 2025 and sugar-reduction policies drive reformulation, forcing rapid portfolio alignment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePublic health priorities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003ePandemic preparedness and antimicrobial stewardship reshape demand for pharma and supplements; AMR is projected to cause 10 million deaths annually by 2050 (O'Neill), reinforcing stewardship-driven demand shifts. Vaccination and immunity agendas, with DTP3 coverage at 81% in 2022 (WHO), drive micronutrient and probiotic uptake. Government procurement increasingly favors compliant, traceable suppliers and public health campaigns shift consumer behavior across food and beauty categories.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePandemic preparedness: higher demand for immune-focused ingredients\u003c\/li\u003e\n\u003cli\u003eAMR risk: 10M deaths by 2050 (O'Neill)\u003c\/li\u003e\n\u003cli\u003eVaccination coverage: DTP3 81% (2022, WHO)\u003c\/li\u003e\n\u003cli\u003eProcurement: preference for traceability and compliance\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndustrial and R\u0026amp;D incentives\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSubsidies and tax credits (e.g., EU Horizon Europe €95.5bn 2021–27 and R\u0026amp;D tax relief up to c.25% in some jurisdictions) materially improve biomanufacturing, green chemistry and circularity project economics, while local-content rules (commonly 20–40%) shape plant siting; participation in public–private innovation programs can accelerate time-to-market by 6–18 months, but political shifts can remove incentives within 1–3 years, requiring flexible capital planning.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSubsidies: Horizon Europe €95.5bn\u003c\/li\u003e\n\u003cli\u003eR\u0026amp;D tax relief: up to c.25%\u003c\/li\u003e\n\u003cli\u003eLocal-content: commonly 20–40%\u003c\/li\u003e\n\u003cli\u003eTime-to-market: −6–18 months\u003c\/li\u003e\n\u003cli\u003ePolicy reversal risk: 1–3 years\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTariff volatility and China\/India API reliance push nearshoring, green biomanufacturing shift\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTrade rules (WTO MFN tariffs ~13.5% ag, ~3.5% chemicals) and ~1,800 trade‑restrictive measures (2022–24) raise tariff volatility and hedging needs. \u0026gt;40% of APIs and many botanicals sourced from China\/India, so diversified footprints and nearshoring are critical. Public health targets (2bn with micronutrient deficiencies; DTP3 81% in 2022) and AMR risk (10M by 2050) shift demand. Subsidies (Horizon Europe €95.5bn) and R\u0026amp;D relief (c.25%) support green biomanufacturing.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eWTO MFN tariffs\u003c\/td\u003e\n\u003ctd\u003eAg 13.5% \/ Chem 3.5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrade measures 2022–24\u003c\/td\u003e\n\u003ctd\u003e~1,800\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAPIs from CN\/IN\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMicronutrient gaps\u003c\/td\u003e\n\u003ctd\u003e~2bn people\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHorizon Europe\u003c\/td\u003e\n\u003ctd\u003e€95.5bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how external macro-environmental factors uniquely affect DSM‑Firmenich across Political, Economic, Social, Technological, Environmental and Legal dimensions, with each section supported by current data and trends to identify threats and opportunities for executives and advisors. Designed for seamless inclusion in reports and pitch decks, it includes forward‑looking insights to support scenario planning and strategic decision‑making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, visually segmented DSM‑Firmenich PESTLE summary that’s easy to share and drop into presentations, customizable with region- or business-specific notes to speed up meetings, strategy sessions, and consultant reports.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCommodity and energy price volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eInput cost volatility for corn, sugar, essential oils, solvents and energy drives margin swings at DSM-Firmenich, with raw-material shocks and EU ETS carbon at about €100\/t in 2024 materially raising processing costs.\u003c\/p\u003e\n\u003cp\u003eHedging and long-term supply contracts smooth price exposure but add procurement complexity and potential margin lag versus spot; sudden commodity spikes force pricing actions and product-mix management.\u003c\/p\u003e\n\u003cp\u003eEnergy-intensive fermentation benefits from renewable PPAs, which firms report can cut power cost exposure and carbon intensity, improving margin resilience versus volatile grid prices.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCurrency fluctuations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDSM-Firmenich's global sales and sourcing expose pro forma 2024 sales of about EUR 10.5bn to FX swings across USD, EUR, CHF, CNY and EM currencies; FX volatility can move reported revenue and margin by several percentage points. Natural hedges and derivatives limit short-term swings but not structural currency shifts. Regional pricing corridors and local production align costs and revenues, while persistent FX moves alter capital allocation and supply-chain investment decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnd-market cycles\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnd-market cycles show food and personal care acting as defensive anchors for DSM-Firmenich, while flavors\/fragrances and pharma intermediates display higher elasticity with price- and volume-sensitive demand. Downtrading during recessions pressures premium fragrance and taste segments but can boost sales of functional, lower-cost basics. Customer destocking and inventory cycles create short-term volume swings and margin variability. Diversification across these end-markets smooths revenue across cycles.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePricing power and mix\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eDistinctive health claims and patented delivery systems allow DSM-Firmenich to command premium pricing, supporting nutrition segment ASPs roughly 10% above category average in 2024; value-based selling tied to clinical efficacy and sustainability has helped lift margins, with pro forma adjusted EBITDA margin targeted near mid-teens. Portfolio pruning in 2024 raised average profitability while commoditized vitamins face margin compression, driving cost-leadership initiatives.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePremium ASPs ~+10% (2024)\u003c\/li\u003e\n\u003cli\u003ePro forma adjusted EBITDA mid-teens (target, 2024)\u003c\/li\u003e\n\u003cli\u003ePortfolio pruning → higher average profit (2024)\u003c\/li\u003e\n\u003cli\u003eCommoditized vitamins → cost leadership pressure\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eM\u0026amp;A and portfolio optimization\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eIndustry consolidation at DSM-Firmenich supports scale in R\u0026amp;D, sourcing and go-to-market, leveraging a pro forma 2023 revenue of about €10bn to fund larger pipeline investments. Strategic divestments free capital to accelerate biotech and wellness platforms while disciplined integration protects projected synergies and customer retention. Heightened antitrust scrutiny, notably in EU\/US reviews, continues to shape deal scope and timing.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eScale: pro forma 2023 revenue ~€10bn\u003c\/li\u003e\n\u003cli\u003eDivestments: free capital for biotech\/wellness\u003c\/li\u003e\n\u003cli\u003eIntegration: safeguards synergies \u0026amp; retention\u003c\/li\u003e\n\u003cli\u003eRegulation: antitrust shapes scope\/timing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTariff volatility and China\/India API reliance push nearshoring, green biomanufacturing shift\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eInput-cost volatility (corn, sugar, oils, energy) and EU ETS at ~€100\/t in 2024 drive margin swings; hedges\/long-term contracts mitigate but add lag. Pro forma 2024 sales ~€10.5bn with FX across USD\/EUR\/CHF\/CNY shifting reported revenue by several ppt. Nutrition ASPs ~+10% and pro forma adjusted EBITDA targeted mid-teens; end-market mix cushions cycles.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePro forma sales\u003c\/td\u003e\n\u003ctd\u003e€10.5bn\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEU ETS price\u003c\/td\u003e\n\u003ctd\u003e~€100\/t\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNutrition ASPs\u003c\/td\u003e\n\u003ctd\u003e+10%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdj. EBITDA target\u003c\/td\u003e\n\u003ctd\u003eMid-teens %\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eWhat You See Is What You Get\u003c\/span\u003e\u003cbr\u003eDSM-Firmenich PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview of the DSM‑Firmenich PESTLE Analysis is the exact document you’ll receive after purchase—fully formatted, professionally structured, and ready to use. No placeholders or teasers; the content, layout, and structure shown are identical to the downloadable file. After checkout you’ll instantly receive this same finished report.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56162577940857,"sku":"dsm-firmenich-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/dsm-firmenich-pestle-analysis.png?v=1762703667","url":"https:\/\/portersfiveforce.com\/products\/dsm-firmenich-pestle-analysis","provider":"Porter's Five Forces","version":"1.0","type":"link"}